Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
Edward Adomako, Biochemist and Molecular Biologist, shared on LinkedIn:
”Thrombotic Thrombocytopenic Purpura (TTP): A Rare but Life-Threatening Medical Emergency
In clinical laboratory medicine, some conditions demand rapid recognition and immediate intervention.
One of these is Thrombotic Thrombocytopenic Purpura (TTP), a rare disorder that can become fatal if not treated promptly.
TTP occurs when there is a severe deficiency of the enzyme ADAMTS13, which normally regulates von Willebrand factor in the blood.
When this enzyme is lacking, abnormal platelet clumping can occur in small blood vessels, leading to microvascular thrombosis.
Key laboratory and clinical features include:
- Severe thrombocytopenia (low platelet count)
- Microangiopathic hemolytic anemia with schistocytes on peripheral smear
- Elevated LDH and bilirubin
- Neurological symptoms such as confusion or seizures
- Possible renal impairment
Historically, clinicians described a ‘pentad’ of symptoms, but in many cases, the combination of thrombocytopenia and hemolytic anemia is enough to raise strong suspicion.
Why early diagnosis matters
Without treatment, mortality from TTP can be extremely high.c
Fortunately, modern therapies such as therapeutic plasma exchange, corticosteroids, and targeted therapies like caplacizumab have dramatically improved survival rates.
The role of the laboratory
Laboratory professionals play a critical role in identifying:
- Schistocytes on peripheral blood smear
- Evidence of hemolysis
- ADAMTS13 activity testing when available
Early laboratory detection can be the difference between rapid life-saving treatment and delayed care.
For healthcare professionals:
Maintaining a high index of suspicion when encountering unexplained thrombocytopenia and hemolytic anemia is crucial.
As laboratory and healthcare professionals, our vigilance helps ensure that rare but critical conditions like TTP are recognized and treated in time.”

Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot MissĀ
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care